In June 2019, a lung symposium was held at the 42nd European Congress of Cytology in Malmö, Sweden. Due to the current importance of cytological samples in the diagnoses and molecular analysis to set up the utmost management of lung cancer patients, cytologists from different countries shared the experience of their institutions. The place of the cytological samples gains more and more importance on the potential long-term survival gain through personalized medicine and this harbors the improvement of the guidelines both in pathology and cytology field. In this symposium, the new 6-tiered reporting system for pulmonary cytology proposed by the Papanicolaou Society of Cytopathology and detailed cytomorphological approach to lung carcinoma including lookalike lesions and DNA- and RNA-based analysis of cytology material have been discussed. The cytopathologist plays a pivotal role in ensuring success of a correct triage for the cytology material to be sure of the adequacy and quality of the yield from the rapid on-site evaluation till the report which should encompass molecular profile in rational patient management.

中文翻译：

---

肺癌细胞学实践的当前主题和实践考虑因素：2019年第42届欧洲细胞学大会肺癌研讨会上的反思。

2019年6月，在瑞典马尔默举行的第42届欧洲细胞学大会上举行了一次肺病研讨会。由于目前细胞学样本在诊断和分子分析方面的重要性，以建立对肺癌患者的最大管理，因此来自不同国家的细胞学家分享了其机构的经验。通过个性化药物，细胞学样本的位置对于潜在的长期生存增长越来越重要，这在病理学和细胞学领域都具有指导性的改进。在本次研讨会中，讨论了由Papanicolaou细胞病理学学会提出的新的6层级肺细胞学报告系统，以及详细的肺癌细胞形态学方法，包括相似的病变以及基于DNA和RNA的细胞学材料分析。